Rentschler Biopharma: A 50-year Legacy of Exceptional CDMO Expertise

Opinion
Video

Sponsored

Conference|DCAT

Explore how Rentschler Biopharma duels biopharmaceutical innovation, spanning from pioneering biological products to cutting-edge cell and gene therapies

Benedikt von Braunmühl (CEO) and Federico Pollano (vice president of business development) at Rentschler Biopharma explain what sets their CDMO apart. Viewers will learn about:

  • What exceptional CDMO expertise means: 25% of all FDA approved biopharmaceuticals in 2023 were supported by the company
  • Rentschler Biopharma’s US offerings, as well as commercial and development expertise
  • How the company is leveraging its expertise in the field of gene therapy
Recent Videos
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Related Content
DCAT Week 2025: Sustainability in Medical Propellants

DCAT Week 2025: Sustainability in Medical Propellants

Patrick Lavery
March 24th 2025
Article

PharmTech Group chatted with Markus Laubscher of Orbia during DCAT Week 2025, covering the topics of sustainability, regulatory hurdles, next-generation innovation, and the DCAT Week experience.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

SGD Pharma Details Latest Sustainability Investments at DCAT Week 2025

Patrick Lavery
March 19th 2025
Article

The company is highlighting its commitment to next-generation glass manufacturing in efforts to strengthen the pharmaceutical supply chain.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Shilpa Biologicals and mAbTree Biologics to Collaborate on Novel Immuno-Oncology Asset

Feliza Mirasol
March 18th 2025
Article

The partnership aims to develop and commercialize a novel checkpoint inhibitor for immuno-oncology applications.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

DCAT Member Companies Present Latest News to Start DCAT Week 2025

Patrick Lavery
March 17th 2025
Article

The Member Company Announcement Forum is the kickoff event of the annual DCAT Week in New York City, which is being held from March 17–20.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025

Patrick Lavery
March 17th 2025
Article

This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Noramco Group Establishes Sterile Injectable Manufacturing Capabilities with $25 Million Investment

Patrick Lavery
March 10th 2025
Article

The investment is intended for the Halo Pharma facility in Whippany, NJ, and aims to help relieve capacity shortages in the injectable supply chain in the United States.